Associate Professor Martin Bauer
Medical University of Vienna, Vienna (Austria)
SAIT - Specific Active immunotherapy (SAIT) against PCSK9 is safe and lowers circulating LDL-C in humans
Event: ESC Congress 2018
Topic: Lipid-Lowering Agents
Session: Late Breaking Pharmacological Science
ESC 365 is supported by
